Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 151 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

10%

15 trials in Phase 3/4

Results Transparency

16%

5 of 31 completed with results

Key Signals

5 with results100% success

Data Visualizations

Phase Distribution

111Total
Not Applicable (86)
P 1 (2)
P 2 (8)
P 3 (9)
P 4 (6)

Trial Status

Recruiting50
Not Yet Recruiting39
Completed31
Active Not Recruiting18
Enrolling By Invitation6
Unknown4

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 31 completed trials

Clinical Trials (151)

Showing 20 of 20 trials
NCT07751705Not ApplicableRecruitingPrimary

Induced Sputum Collection in COPD Patients With and Without a Vibroacoustic Device

NCT07749001Phase 4Not Yet RecruitingPrimary

Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab

NCT07750821Not ApplicableRecruitingPrimary

Balance Training Following Pulmonary Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease (COPD)

NCT07751003Not ApplicableNot Yet RecruitingPrimary

Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support

NCT07742085Not ApplicableCompletedPrimary

Self-Management in Adults With Asthma or COPD

NCT06958666Not ApplicableRecruitingPrimary

Effectiveness of DITM Versus IMT in COPD Patients

NCT07719192Not ApplicableNot Yet RecruitingPrimary

Effects of Alternate Nostril Breathing and Bellows Breath in COPD Patients

NCT07704567Not ApplicableRecruitingPrimary

MoblO2 to Maintain Oxygenation

NCT03197818Phase 3CompletedPrimary

Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD) (TRIVERSYTI)

NCT07713043Not ApplicableNot Yet RecruitingPrimary

Effects of Autogenic Drainage and Flutter Device in COPD

NCT06780046RecruitingPrimary

Study That Will Evaluate the Brazilian Population With COPD.

NCT07703527Not ApplicableNot Yet RecruitingPrimary

Modulating Locomotor-Respiratory Coupling Through Adaptive Exoskeleton Assistance in Patients With COPD

NCT07262229Not ApplicableActive Not RecruitingPrimary

Self-management Digital Intervention to Promote Physical Activity in People Living With COPD

NCT06884228Not ApplicableActive Not RecruitingPrimary

Effects of Vibrating Mesh Nebulisation in Patients With COPD During Non-invasive Ventilation (VMN-NIV)

NCT06969573Phase 2Active Not RecruitingPrimary

Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD

NCT07602192Recruiting

Quantitative Chest CT and Multi-Omics to Distinguish Asthma From COPD and Predict Treatment Response

NCT07612878Not Yet RecruitingPrimary

The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry

NCT04820257Not ApplicableNot Yet RecruitingPrimary

Home-based Pulmonary Rehabilitation for COPD Patients

NCT07666841Not ApplicableNot Yet RecruitingPrimary

Tele-Pulmonary Rehabilitation For Patients With Chronic Lung Diseases

NCT06283966Phase 3RecruitingPrimary

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Scroll to load more

Research Network

Activity Timeline